You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: A two-year, randomized, placebo-controlled study
|
|---|---|
| Published in |
Clinical Therapeutics, November 2003
|
| DOI | 10.1016/s0149-2918(03)80334-x |
| Pubmed ID | |
| Authors |
Ming-Hsiung Hsieh, Paul Chan, Yuh-Mou Sue, Ju-Chi Liu, Toong Hua Liang, Tsuei-Yuen Huang, Brian Tomlinson, Moses Sing Sum Chow, Pai-Feng Kao, Yi-Jen Chen |
| Abstract |
Stevioside, a natural glycoside isolated from the plant Stevia rebaudiana Bertoni, has been used as a commercial sweetening agent in Japan and Brazil for >20 years. Previous animal and human studies have indicated that stevioside has an antihypertensive effect. |
X Demographics
The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 18% |
| Unknown | 9 | 82% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 82% |
| Science communicators (journalists, bloggers, editors) | 1 | 9% |
| Unknown | 1 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 208 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 3 | 1% |
| United States | 2 | <1% |
| Mexico | 1 | <1% |
| Belgium | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 200 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 40 | 19% |
| Student > Bachelor | 30 | 14% |
| Researcher | 29 | 14% |
| Student > Ph. D. Student | 25 | 12% |
| Other | 9 | 4% |
| Other | 29 | 14% |
| Unknown | 46 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 47 | 23% |
| Agricultural and Biological Sciences | 32 | 15% |
| Biochemistry, Genetics and Molecular Biology | 15 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 5% |
| Chemistry | 11 | 5% |
| Other | 30 | 14% |
| Unknown | 62 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 83. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 September 2023.
All research outputs
#513,971
of 25,402,889 outputs
Outputs from Clinical Therapeutics
#38
of 3,852 outputs
Outputs of similar age
#420
of 57,110 outputs
Outputs of similar age from Clinical Therapeutics
#1
of 27 outputs
Altmetric has tracked 25,402,889 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,852 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 57,110 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.